Results 141 to 150 of about 1,543,622 (248)

Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia [PDF]

open access: gold, 2018
Shqipe Gerguri   +11 more
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Clinical Pathways in Managing High-Caries Children with Adverse Dental Histories. [PDF]

open access: yesMedicina (Kaunas)
Hashemi F   +3 more
europepmc   +1 more source

The Association of Cell-Free LncH19 and miR-29b Expression with the PI3K/AKT/HIF-1/VEGF Pathway in Patients with Diabetic Nephropathy: In Silico Prediction and Clinical Validation [PDF]

open access: gold
Noha M. Abd El‐Fadeal   +10 more
openalex   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

open access: yesMolecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller   +17 more
wiley   +1 more source

Enhancing neuropsychological assessment clinical pathways in Parkinson's disease through the use of technology. [PDF]

open access: yesFront Digit Health
Lobo EH   +10 more
europepmc   +1 more source

TREX1, a predator for treating MSI‐H tumors?

open access: yesMolecular Oncology, EarlyView.
Immunotherapy benefits many patients; yet, some with MSI‐H tumors remain unresponsive despite their high immunogenicity. Xu et al. reveal that TREX1 enables immune evasion by degrading cytosolic DNA and suppressing cGAS–STING–IFN‐I signaling. TREX1 loss restores DNA sensing, increases CD8+ T and NK cell infiltration, and boosts antitumor immunity ...
Elena Benidovskaya   +2 more
wiley   +1 more source

Proyecto de mejora de la asistencia sanitaria (MAS): estudio multicéntrico y multidisciplinar. Primeras conclusiones

open access: yesMedicina y Seguridad del Trabajo
Definir el método de trabajo utilizado en el estudio de la Calidad Asistencial de accidentes de trabajo leves, siguiendo las fases del proceso (estudio del proceso desde su entrada en admisión, la historia clínica, la comunicación entre servicios ...
Carolina Gerónimo Blasco   +4 more
doaj  

Home - About - Disclaimer - Privacy